412 related articles for article (PubMed ID: 27748801)
21. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
Su J; Wu S; Tang W; Qian H; Zhou H; Guo T
Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225
[TBL] [Abstract][Full Text] [Related]
22. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death.
Ametller E; García-Recio S; Pastor-Arroyo EM; Callejo G; Carbó N; Gascón P; Almendro V
Cancer Biol Ther; 2011 Jan; 11(1):4-13. PubMed ID: 20980803
[TBL] [Abstract][Full Text] [Related]
24. Enhanced TLR4 Expression on Colon Cancer Cells After Chemotherapy Promotes Cell Survival and Epithelial-Mesenchymal Transition Through Phosphorylation of GSK3β.
Chung YH; Kim D
Anticancer Res; 2016 Jul; 36(7):3383-94. PubMed ID: 27354597
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
[TBL] [Abstract][Full Text] [Related]
26. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
Pedraz-Cuesta E; Christensen S; Jensen AA; Jensen NF; Bunch L; Romer MU; Brünner N; Stenvang J; Pedersen SF
BMC Cancer; 2015 May; 15():411. PubMed ID: 25981639
[TBL] [Abstract][Full Text] [Related]
27. Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features.
Was H; Czarnecka J; Kominek A; Barszcz K; Bernas T; Piwocka K; Kaminska B
Cancer Biol Ther; 2018 Jan; 19(1):63-75. PubMed ID: 29053388
[TBL] [Abstract][Full Text] [Related]
28. SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells.
Planutis AK; Holcombe RF; Planoutene MV; Planoutis KS
Anticancer Drugs; 2015 Oct; 26(9):942-7. PubMed ID: 26196680
[TBL] [Abstract][Full Text] [Related]
29. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X
Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357
[TBL] [Abstract][Full Text] [Related]
31. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
32. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
33. New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells.
Botchkina GI; Zuniga ES; Das M; Wang Y; Wang H; Zhu S; Savitt AG; Rowehl RA; Leyfman Y; Ju J; Shroyer K; Ojima I
Mol Cancer; 2010 Jul; 9():192. PubMed ID: 20630067
[TBL] [Abstract][Full Text] [Related]
34. Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance.
Kalimutho M; Minutolo A; Grelli S; Formosa A; Sancesario G; Valentini A; Federici G; Bernardini S
Cancer Chemother Pharmacol; 2011 Jun; 67(6):1299-312. PubMed ID: 20734047
[TBL] [Abstract][Full Text] [Related]
35. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP.
Tang H; Liu YJ; Liu M; Li X
Anticancer Drugs; 2007 Jul; 18(6):633-9. PubMed ID: 17762391
[TBL] [Abstract][Full Text] [Related]
36. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells.
Genovese S; Epifano F; Preziuso F; Slater J; Nangia-Makker P; Majumdar APN; Fiorito S
Biochem Biophys Res Commun; 2020 Jan; 522(1):95-99. PubMed ID: 31740005
[TBL] [Abstract][Full Text] [Related]
37. MiR-125a/b regulates the activation of cancer stem cells in paclitaxel-resistant colon cancer.
Chen J; Chen Y; Chen Z
Cancer Invest; 2013 Jan; 31(1):17-23. PubMed ID: 23327190
[TBL] [Abstract][Full Text] [Related]
38. Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines.
Dong TT; Zhou HM; Wang LL; Feng B; Lv B; Zheng MH
Ann Surg Oncol; 2011 Jun; 18(6):1797-804. PubMed ID: 21267784
[TBL] [Abstract][Full Text] [Related]
39. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
40. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
Chang TC; Yeh CT; Adebayo BO; Lin YC; Deng L; Rao YK; Huang CC; Lee WH; Wu AT; Hsiao M; Wu CH; Wang LS; Tzeng YM
Toxicol Appl Pharmacol; 2015 Oct; 288(2):258-68. PubMed ID: 26235807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]